- Report
- January 2025
- 200 Pages
Global
From €2266EUR$2,490USD£1,943GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 210 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 200 Pages
India
From €2266EUR$2,490USD£1,943GBP
- Report
- February 2022
- 149 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Nitrofurantoin is an antibiotic used to treat urinary tract infections. It is a synthetic nitrofuran derivative and is available in both oral and intravenous forms. It is effective against a wide range of Gram-positive and Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Nitrofurantoin is generally well-tolerated and has few side effects. It is often used as a first-line treatment for uncomplicated urinary tract infections.
Nitrofurantoin is available in many countries, including the United States, Canada, and the United Kingdom. It is available in both generic and brand-name formulations. The cost of nitrofurantoin varies depending on the country and the formulation.
Some companies in the nitrofurantoin market include Pfizer, Merck, GlaxoSmithKline, and Teva Pharmaceuticals. Show Less Read more